Class of 1999: David M. Berman, M.D., Ph.D., has been named Head of Research and Development at Immunocore Ltd., a leading T-cell receptor biotechnology company. Previously, Dr. Berman worked in immune-oncology programs at both AstraZeneca and Bristol-Myers Squibb.